Watch for Mounjaro, a New Injectable Diabetes Med

There’s buzz about Mounjaro (tirzepatide), a new Rx injectable for type 2 diabetes.

You’ll hear that it’s the first “twincretin.”

That’s because this GLP-1/GIP agonist works in two ways to mimic incretins...hormones that help increase insulin release, decrease blood sugar, and promote fullness, especially after meals.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote